Iteos Therapeutics Inc (ITOS) — Cash Flow Reinvestment Rate
Iteos Therapeutics Inc (ITOS) has a Cash Flow Reinvestment Rate of 2.50x as of December 2024, reinvesting $13.77 Million (capex $152.00K plus investments $13.62 Million) from operating cash flow of $5.50 Million. Explore Iteos Therapeutics Inc capital reinvestment ratio to see what proportion of operating cash flow is directed to capital expenditures.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Iteos Therapeutics Inc Cash Flow Reinvestment Rate (2021–2021)
Historical reinvestment intensity for Iteos Therapeutics Inc across 1 annual periods. Also explore ITOS asset base for the complete picture of this company's asset base.
Annual Cash Flow Reinvestment Rate for Iteos Therapeutics Inc (2021–2021)
Year-by-year capital reinvestment analysis for Iteos Therapeutics Inc. For live market cap and broader valuation context, see Iteos Therapeutics Inc (ITOS) total market value.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2021 | 0.00x | $2.42 Million | $513.14 Million | $1.18 Million | — |